Literature DB >> 6270183

Effect of dibutyryl adenosine 3',5'-monophosphate administration on plasma concentrations of 1,25-dihydroxyvitamin D in pseudohypoparathyroidism type I.

K Yamaoka, Y Seino, M Ishida, T Ishii, T Shimotsuji, Y Tanaka, H Kurose, S Matsuda, K Satomura, H Yabuuchi.   

Abstract

The effect of dibutyryl cAMP on plasma concentrations of 1,25-dihydroxyvitamin D [1,25-(OH)2D] was studied in two patients with pseudohypoparathyroidism (PHP) type I, five normal adults, and three normal children as controls. In normal adults, plasma 1,25-(OH)2D tended to increase 3 h after the infusion of 2.5 mg/kg dbcAMP and was significantly increased after 6 h. In normal children, plasma 1,25-(OH)2D increased 3 h after the infusion, then gradually decreased; in the patients with PHP type I, it increased greatly from 6.8 and 11.2 pg/ml to 264.6 and 128.2 pg/ml 3 h after the infusion. These results suggest that the renal mechanism for the response to parathyroid hormone is intact distal to the renal adenylate cyclase in patients with PHP type I.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270183     DOI: 10.1210/jcem-53-5-1096

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  A 6-hour human parathyroid hormone (1-34) infusion protocol: studies in normal and hypoparathyroid subjects.

Authors:  A McElduff; D Lissner; M Wilkinson; C Cornish; S Posen
Journal:  Calcif Tissue Int       Date:  1987-11       Impact factor: 4.333

Review 2.  Vitamin D-endocrine system.

Authors:  N H Bell
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

3.  Effects of weight loss on serum 1,25-(OH)2-vitamin D concentrations in adults: a preliminary report.

Authors:  J Lemann; R W Gray; W J Maierhofer; N D Adams
Journal:  Calcif Tissue Int       Date:  1984-03       Impact factor: 4.333

4.  The effect of endogenous parathyroid hormone, exogenous calcitonin, and dibutyryl cyclic AMP on urinary excretion of N-acetyl-beta-D-glucosaminidase.

Authors:  K Mizunashi; Y Furukawa; K Yoshinaga
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

5.  1,25(OH)2D and 24,25(OH)2D production in the developing kidney.

Authors:  M Ishida; M Shima; Y Seino
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

6.  A hypercalcemic nude rat model that completely mimics human syndrome of humoral hypercalcemia of malignancy.

Authors:  K Ikeda; T Matsumoto; S Fukumoto; K Kurokawa; Y Ueyama; K Fujishige; N Tamaoki; T Saito; K Ohtake; E Ogata
Journal:  Calcif Tissue Int       Date:  1988-08       Impact factor: 4.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.